Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: A preliminary study [7]

Leukemia and Lymphoma

Volumn 48, Issue 7, 2007, Pages 1429-1433

  Yamanaka, Ryuya ^a,b   Homma, Junpei ^a   Sano, Masakazu ^a   Tsuchiya, Naoto ^a   Yajima, Naoki ^a   Takahashi, Hideaki ^a   Shinbo, Yoshikatsu ^a   Hasegawa, Akira ^c   Saitoh, Takashi ^d   Tanaka, Ryuichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kobari Hospital   (Japan)

^d NAGANO RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOPLATIN; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ELECTROLYTE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; PROCARBAZINE; RANIMUSTINE; RITUXIMAB; UREA; VINCRISTINE;

ADULT; AGED; ANEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER GROWTH; CANCER IMMUNOTHERAPY; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EYE CANCER; FEMALE; HUMAN; HYPONATREMIA; INFORMED CONSENT; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; LIVER DISEASE; LYMPHOMATOSIS; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PILOT STUDY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT REFUSAL; VOMITING;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYTARABINE; DEXAMETHASONE; FEMALE; HUMANS; IMMUNOTHERAPY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MITOXANTRONE; SALVAGE THERAPY;

EID: 34447553483     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701370605     Document Type: Letter

References (15)

1. Abrey, L. E., Yahalom, J. and DeAngelis, L. M. (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol, 18, pp. 3144-3150.
2. O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M. and Poulsen, M. (2000) Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol, 18, pp. 519-526.
3. Brada, M., Hjiyiannakis, D., Hines, F., Traish, D. and Ashley, S. (1998) Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). Int J Radiat Oncol Biol Phys, 40, pp. 1157-1162.
4. Poortmans, P., Kluin-Nelemans, H. C., Haaxma-Reiche, H., Veer, M Van't, Hansen, M. and Soubeyran, P. (2003) High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol, 21, pp. 4483-4488.
5. Reni, M., Ferreri, A. J. and Villa, E. (1999) Second-line treatment for primary central nervous system lymphoma. Br J Cancer, 79, pp. 530-534.
6. Cher, L., Glass, J., Harsh, G. R. and Hochberg, F. H. (1996) Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: Preliminary results. Neurology, 46, pp. 1757-1759.
7. Enting, R. H., Demopoulos, A., DeAngelis, L. M. and Abrey, L. E. (2004) Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology, 63, pp. 901-903.
8. Abrey, L. E., Moskowitz, C. H., Mason, W. P., Crump, M., Stewart, D. and Forsyth, P. (2003) Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis. J Clin Oncol, 21, pp. 4151-4156.
9. Coltman Jr, C. A., Coltman, T. M., Balcerzak, S. P., Morrison, F. S. and Von Hoff, D. D. (1984) Mitoxantrone in refractory non-Hodgkin's lymphoma. A Southwest Oncology Group study. Semin Oncol, 11, pp. 50-53.
10. Yamanaka, R., Morii, K., Shinbo, Y., Takeuchi, S., Tamura, T. and Hondoh, H. (2005) Modified ProMACE-MOPP hybrid regimen with moderate dose methotrexate for patients with primary CNS lymphoma. Ann Hematol, 84, pp. 447-455.
11. Yamanaka, R., Homma, J., Sano, M., Tsuchiya, N., Yajima, N. and Shinbo, Y. Immuo-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma - preliminary report. Leuk Lymphoma
12. Plotkin, S. R., Betensky, R. A., Hochberg, F. H., Grossman, S. A., Lesser, G. J. and Nabors, L. B. (2004) Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res, 10, pp. 5643-5646.
13. Herrlinger, U., Schabet, M., Brugger, W., Kortmann, R. D., Kuker, W. and Deckert, M. (2002) German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol, 51, pp. 247-252.
14. Fischer, L., Thiel, E., Klasen, H. A., Birkmann, J., Jahnke, K. and Martus, P. (2006) Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol, 17, pp. 1141-1145.
15. Reni, M., Mason, W., Zaja, F., Perry, J., Franceschi, E. and Bernardi, D. (2004) Salvage chemotherapy with temozolomide in primary CNS lymphomas: Preliminary results of a phase II trial. Eur J Cancer, 40, pp. 1682-1688.